Mordechai Muszkat

researcher

Born 2000-01-01

Mordechai Muszkat is …
instance of (P31):
humanQ5

External links are
P8189J9U ID987009461664805171
P496ORCID iD0000-0002-9520-1379
P1153Scopus author ID56370695200
P214VIAF cluster ID28161451312864100639

P108employerHebrew University of JerusalemQ174158
Hadassah Medical CenterQ2331605
P735given nameMordecaiQ3862863
MordecaiQ3862863
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q44413115A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade
Q37551273A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction
Q44680942Alpha2-adrenergic receptor-induced vascular constriction in blacks and whites
Q46466416Alpha2B adrenergic receptor 301-303 deletion polymorphism and vascular alpha2 adrenergic receptor response
Q37375138Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.
Q36769250Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites.
Q35962388CYP2A6 genetic variation and dexmedetomidine disposition
Q40174813CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.
Q47915074Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia.
Q35830926Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.
Q34199742Co-occurrence of hepatocellular carcinoma and lymphoma in patients with hepatitis C virus cirrhosis.
Q43809494Compound cardiac toxicity of oral erythromycin and verapamil
Q33848602Coronary vasospasm associated with uncontrolled carcinoid tumour
Q78245072Corticosteroid-induced glaucoma attributable to an adrenocorticotropin-secreting malignant carcinoid tumor of the thymus
Q33955008Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.
Q46990629Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier
Q46536462Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects
Q42720508Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study
Q43141103Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults.
Q38970144Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamine
Q33625202Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception.
Q33410725Estimation of the warfarin dose with clinical and pharmacogenetic data
Q46741321Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine
Q53142338Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers
Q42607183Factors associated with bleeding in elderly hospitalized patients treated with enoxaparin sodium : a prospective, open-label, observational study.
Q74709236Factors associated with mortality among elderly patients with hypothermia
Q74294023Fulminant Cushing's syndrome due to an ACTH-producing thymic carcinoid
Q33646237GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
Q37210441Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.
Q35658737Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.
Q37351724Genetic variation in the alpha1B-adrenergic receptor and vascular response.
Q34731144Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans
Q35642517Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.
Q34827577Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine
Q43923513Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Q28385491Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo
Q28290776Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9
Q44862814Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial
Q45744200Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly
Q73616904Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine
Q28206334Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine
Q38719983Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials.
Q43856655Major bleeding caused by warfarin in a genetically susceptible patient
Q51719612Massive subcutaneous emphysema in a long-term ventilated patient
Q43513507Mefloquine-induced acute hepatitis
Q73769062Natural course of insulin edema
Q36056712Pharmacogenetics and response to beta-adrenergic receptor antagonists in heart failure
Q43773276Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo
Q44351201Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients
Q40343196Population pharmacokinetic analysis of the active product of dipyrone
Q34730029Post-partum hypocalcemia: idiopatic hypoparathyroidism manifested early in lactation
Q38384338Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects.
Q51646835Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors
Q84269736Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control study
Q34086360Safety of low dose methotrexate in elderly patients with rheumatoid arthritis
Q44340794Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein
Q33445972Teaching empathy through poetry: a clinically based model
Q87891839The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies
Q85325962The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals
Q33462930The effect of medical students' gender, ethnicity and attitude towards poetry-reading on the evaluation of a required, clinically-integrated poetry-based educational intervention
Q96811347The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: a nested case-control study
Q74586910The evaluation of pleural effusions in patients with heart failure
Q33504648Ticlopidine-induced thrombotic thrombocytopenic purpura.
Q78723116Use of complementary alternative medicine in patients admitted to internal medicine wards
Q46495946Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivo.
Q37209353Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.
Q46972798Variations in the alpha2A-adrenergic receptor gene and their functional effects.
Q80496694Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions
Q28395337Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Search more.